Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases

Clinical Immunology

Volumn 129, Issue 3, 2008, Pages 509-517

  Saresella, Marina ^a   Marventano, Ivana ^a   Guerini, Franca Rosa ^a   Zanzottera, Milena ^a   Delbue, Serena ^b   Marchioni, Enrico ^c   Maserati, Renato ^d   Longhi, Renato ^e   Ferrante, Pasquale ^b   Clerici, Mario ^a,b  

^a IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e CNR   (Italy)

Author keywords

Apoptosis; Demyelinating diseases; Multiple sclerosis; Myelin basic protein; PCD

Indexed keywords

MYELIN BASIC PROTEIN;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NOT DETERMINED LEUKOENCEPHALOPATHY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DEMYELINATING DISEASES; DNA, VIRAL; FEMALE; FLOW CYTOMETRY; HUMANS; JC VIRUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 55249115302     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.08.010     Document Type: Article

References (24)

1. Mayo J., Collazos J., and Martínez E. Progressive multifocal leukoencephalopathy following initiation of highly active antiretroviral therapy. AIDS 12 (1998) 1720-1722
2. Clifford D.B., Yiannoutsos C., Glicksman M., Simpson D.M., Singer E.J., Piliero P.J., Marra C.M., Francis G.S., McArthur J.C., Tyler K.L., Tselis A.C., and Hyslop N.E. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52 (1999) 623-625
3. Albrecht H., Hoffmann C., Degen O., Stoehr A., Plettenberg A., Mertenskotter T., Eggers C., and Stellbrink H.J. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12 (1998) 1149-1154
4. Antinori A., Cingolani A., Lorenzini P., Giancola M.L., Uccella I., Bossolasco S., Grisetti S., Moretti F., Vigo B., Bongiovanni M., Del Grosso B., Arcidiacono M.I., Fibbia G.C., Mena M., Finazzi M.G., Guaraldi G., Ammassari A., d'Arminio Monforte A., Cinque P., De Luca A., and Italian Registry Investigative Neuro AIDS Study Group. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J. Neurovirol. 9 (2003) 47-53
5. Safdar A., Rubocki R.J., Horvath J.A., Narayan K.K., and Waldron R.L. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin. Infect. Dis. 15 (2002) 1250-1257
6. Koralnik I.J. New insights into progressive multifocal leukoencephalopathy. Curr. Opin. Neurol. 17 (2004) 365-370
7. Di Giambenedetto S., Vago G., Pompucci A., Scoppettuolo G., Cingolani A., Marzocchetti A., Tumbarello M., Cauda R., and De Luca A. Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?. Neurology 28 (2004) 2452-2453
8. Tanaka M., and Miyake Y. Apoptotic cell clearance and autoimmune disorder. Curr. Med. Chem. 14 (2007) 2892-2897
9. Siegel R.M., Chan F.K.-M., and Lenardo M.J. The multifaceted role of Fas signaling in immune cells homeostasis and autoimmunity. Nat. Immunol. 1 (2000) 469-474
10. Saresella M., Marventano I., Speciale L., Ruzzante S., Trabattoni D., Della Bella S., Filippi M., Fasano F., Cavarretta R., Caputo D., Clerici M., and Ferrante P. Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis. J. Neuroimmunol. 166 (2005) 173-179
11. Delbue S., Sotgiu G., Fumagalli D., Valli M., Borghi E., Mancuso R., Marchioni E., Maserati R., and Ferrante P. A case of a PML patient with four different JC virus TCR rearrangements in CSF, blood, serum and urine. J. Neurovirol. 11 (2005) 51-57
12. Magri G., Clerici M., Dall'Ara P., Biasin M., Caramelli M., Casalone C., Giannino M.L., Longhi R., Piacentini L., Della Bella S., Gazzuola P., Martino P.A., Pollera C., Puricelli M., Servida F., Crescio I., Boasso A., Ponti W., and Poli G. Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters. Vaccine 23 (2005) 2862-2868
13. Lecoeur H., Ledru E., Prèvost M.C., and Gougeont M.L. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. J. Immunol. Methods 209 (1997) 111-123
14. Lecoeur H., Ledru E., and Gougeont M.L. A cytofluorimetric method for the imultaneous detection of both intracellular and surface antigens of apoptotic peripheral lymphocytes. J. Immunol. Methods 217 (1998) 11-26
15. Lyons A.B. Anlaysing cell division in vivo and in vitro using flow cytometric measurement of CSFE dye dilution. J. Immunol. Methods 243 (2000) 147-154
16. Crawford M.P., Yan S.X., Ortega S.B., Mehta R.S., Hewitt R.E., Price D.A., Stastny P., Douek D.C., Koup R.A., Racke M.K., and Karandikar N.J. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103 11 (2004 Jun 1) 4222-4231
17. Maniati E., Potter P., Rogers N.J., and Morley B.J. Control of apoptosis in autoimmunity. J. Pathol. 214 (2008) 190-198
18. Berger J.R., and Major E.O. Progressive multifocal leukoencephalopathy. Semin. Neurol. 19 (1999) 193-200
19. Koralnik I. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?. Ann. Neurol. 60 (2006) 162-173
20. Du Pasquier R.A., Kuroda M.J., Schmitz J.E., Zheng Y., Martin K., Peyerl F.W., Lifton M., Gorgone D., Autissier P., Letvin N.L., and Koralnik I.J. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J. Virol. 77 (2003) 11918-11926
21. Delbue S., Marchioni E., Sotgiu G., Saresella M., Tavazzi E., Colombo E., Guerini F.R., Maserati R., Sinforiani E., Schifino M.R., and Ferrante P. Longitudinal study of two cases of progressive multifocal leukoencephalopathy with a clinical benign evolution. J. Neurovirol. 13 (2007) 268-273
22. Langford T.D., Letendre S.L., Marcotte T.D., Ellis R.J., McCutchan J.A., Grant I., Mallory M.E., Hansen L.A., Archibald S., Jernigan T., and Masliah E. HNRC Group. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16 (2002) 1019-1029
23. Du Pasquier R.A., Stein M.C., Lima M.A., Dang X., Jean-Jacques J., Zheng Y., Letvin N.L., and Koralnik I.J. JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients. J. Neuroimmunol. 176 (2006) 181-186
24. Zimmermann K.C., and Green D.R. The machinery of programmed cell death. Pharmacol. Ther. 92 (2001) 57-70